Roche Diabetes Care has teamed up with a highly regarded American university to create a test bed for innovative solutions for people with type 2 diabetes.
The company has partnered with Duke University in North Carolina to create new breakthrough products, services, and solutions for people with type 2 diabetes.
The university’s specialists will design, establish and curate a well-characterized test site to enable the collection of feedback from people with type 2 diabetes as well as clinical stakeholders.
Digital health solutions
Socio-economic and clinical demographic information from the cohort identified under scrutiny will provide fundamental steps that will enable real-world feedback and help build the evidence needed for digital health solutions for diabetes.
Jim Lefevere, international director of non-insulin therapy solutions at Roche Diabetes Care, said, “For the next three years the partnership will support our strategy of generating real evidence and bringing more innovative solutions to market for people with type 2 diabetes.
“Setting up a test bed with a known partner is an important next step in evaluating novel approaches and deciding whether users will adopt an innovative product. Not only will this accelerate the generation of evidence on how different personalized solutions for patients can lead to better outcomes, but it will also support innovation and pilot projects with external digital health startups and companies. “
Dr. Satasuk Joy Bhosai, director of digital health innovation efforts at Duke, said, “The digital health arena is in desperate need of partnerships that advance evidence-based interventions. Too much technology is being built without enough independently validated evidence to support the claims. To improve care we need to assess the impact, and I am thrilled that this partnership is paying attention to developing meaningful technologies with and for patients. “
This is the beginning of what we at Roche Diabetes Care hope to become a long-term partnership. The aim of the partnership is to enable a large pool of at least 500-1,000 participants who have agreed to work with Roche and have already been recruited for research. This will help provide the evidence needed for diabetes digital health solutions to bring real relief to people with type 2 diabetes.
Photo by Cytonn Photography on Unsplash
